Efficacy Study of Aminoflavone Prodrug to Treat Breast Cancer

Status:
Withdrawn

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

This is a phase II study to assess the efficacy of Aminoflavone prodrug in triple negative and ER+ breast cancer.

Phase 2

Tigris Pharmaceuticals